80 FR 26064 - Center for Scientific Review; Notice of Closed Meetings
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 80, Issue 87 (May 6, 2015)
National Institutes of Health
Federal Register Volume 80, Issue 87 (May 6, 2015)
| Page Range | 26064-26065 | |
| FR Document | 2015-10496 |
[Federal Register Volume 80, Number 87 (Wednesday, May 6, 2015)] [Notices] [Pages 26064-26065] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-10496] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Selected Topics and Transfusion Medicine. Date: June 1-2, 2015. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health; 6701 Rockledge Drive; Bethesda, MD 20892; (Virtual Meeting). Contact Person: Bukhtiar H Shah, DVM, Ph.D.; Scientific Review Officer; Center for Scientific Review; National Institutes of Health; 6701 Rockledge Drive, Room 4120, MSC 7802; Bethesda, MD 20892; 301-806-7314; [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Selected Topics and Transfusion Medicine. Date: June 1-2, 2015. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health; 6701 Rockledge Drive; Bethesda, MD 20892; (Virtual Meeting). Contact Person: Katherine M Malinda, Ph.D.; Scientific Review Officer; Center for Scientific Review; National Institutes of Health; 6701 Rockledge Drive, Room 4140, MSC 7814; Bethesda, MD 20892; 301-435-0912; [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Child Psychopathology and Developmental Disabilities. Date: June 2-3, 2015. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health; 6701 Rockledge Drive; Bethesda, MD 20892; (Virtual Meeting). Contact Person: Jane A. Doussard-Roosevelt, Ph.D.; Scientific Review Officer; Center for Scientific Review; National Institutes of Health; 6701 Rockledge Drive, Room 3184, MSC 7848; Bethesda, MD 20892; (301) 435-4445; [email protected]. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review Group; Pathophysiological Basis of Mental Disorders and Addictions Study Section. Date: June 3-4, 2015. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: The Warwick Allerton Hotel; 701 North Michigan Avenue; Chicago, IL 60611. Contact Person: Boris P Sokolov, Ph.D.; Scientific Review Officer; Center for Scientific Review; National Institutes of Health; 6701 Rockledge Drive, Room 5217A, MSC 7846; Bethesda, MD 20892; 301-408-9115; [email protected]. Name of Committee: Vascular and Hematology Integrated Review Group; Molecular and Cellular Hematology Study Section. Date: June 3-4, 2015. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion; 4300 Military Road NW.; Washington, DC 20015. Contact Person: Luis Espinoza, Ph.D.; Scientific Review Officer; Center for Scientific Review; National Institutes of Health; 6701 Rockledge Drive, Room 6183, MSC 7804; Bethesda, MD 20892; 301-495- 1213; [email protected]. Name of Committee: Biobehavioral and Behavioral Processes Integrated Review Group; Cognition and Perception Study Section. Date: June 4-5, 2015. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Historic Inns of Annapolis; 58 State Circle; Annapolis, MD 21401. Contact Person: Dana Jeffrey Plude, Ph.D.; Scientific Review Officer; Center for Scientific Review; National Institutes of Health; 6701 Rockledge Drive, Room 3176, MSC 7848; Bethesda, MD 20892; (301) 435-2309; [email protected]. Name of Committee: Biology of Development and Aging Integrated Review Group; International and Cooperative Projects--1 Study Section. Date: June 4, 2015. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Villa Florence Hotel; 225 Powell Street; San Francisco, CA 94102. Contact Person: Hilary D Sigmon, Ph.D.; Scientific Review Officer; Center for Scientific Review; National Institutes of Health; 6701 Rockledge Drive, Room 5222, MSC 7852; Bethesda, MD 20892; (301) 594-6377; [email protected]. Name of Committee: Risk, Prevention and Health Behavior Integrated Review Group; [[Page 26065]] Psychosocial Development, Risk and Prevention Study Section. Date: June 4-5, 2015. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Kinzie Hotel; 20 W Kinzie Street; Chicago, IL 60654. Contact Person: Anna L Riley, Ph.D.; Scientific Review Officer; Center for Scientific Review; National Institutes of Health; 6701 Rockledge Drive, Room 3114, MSC 7759; Bethesda, MD 20892; (301) 435- 2889; [email protected]. Name of Committee: Emerging Technologies and Training Neurosciences Integrated Review Group; Molecular Neurogenetics Study Section. Date: June 4-5, 2015. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Mayflower Park Hotel; 405 Olive Way; Seattle, WA 98101. Contact Person: Eugene Carstea, Ph.D.; Scientific Review Officer; Center for Scientific Review; National Institutes of Health; 6701 Rockledge Drive, Room 5194, MSC 7846; Bethesda, MD 20892; (301) 408-9756; [email protected]. Name of Committee: Immunology Integrated Review Group; Transplantation, Tolerance, and Tumor Immunology Study Section. Date: June 4-5, 2015. Time: 8:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Marriott Wardman Park Washington DC Hotel; 2660 Woodley Road NW.; Washington, DC 20008. Contact Person: Jin Huang, Ph.D.; Scientific Review Officer; Center for Scientific Review; National Institutes of Health; 6701 Rockledge Drive, Room 4199, MSC 7812; Bethesda, MD 20892; 301-435- 1230; [email protected]. Name of Committee: Immunology Integrated Review Group; Hypersensitivity, Autoimmune, and Immune-mediated Diseases Study Section. Date: June 4-5, 2015. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Washington Plaza Hotel; 10 Thomas Circle, NW.; Washington, DC 20005. Contact Person: Bahiru Gametchu, DVM, Ph.D.; Scientific Review Officer; Center for Scientific Review; National Institutes of Health; 6701 Rockledge Drive, Room 4204, MSC 7812; Bethesda, MD 20892; 301-408-9329; [email protected]. Name of Committee: Cell Biology Integrated Review Group; Cellular Mechanisms in Aging and Development Study Section. Date: June 4-5, 2015. Time: 8:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: St. Gregory Hotel; 2033 M Street NW.; Washington, DC 20036. Contact Person: John Burch, Ph.D.; Scientific Review Officer; Center for Scientific Review; National Institute of Health; 6701 Rockledge Drive, Room 3213, MSC 7808; Bethesda, MD 20892; 301-408- 9519; [email protected]. Name of Committee: Biological Chemistry and Macromolecular Biophysics Integrated Review Group; Synthetic and Biological Chemistry B Study Section. Date: June 4-5, 2015. Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Pier 5 Hotel; 711 Eastern Avenue; Baltimore, MD 21202. Contact Person: Kathryn M Koeller, Ph.D.; Scientific Review Officer; Center for Scientific Review; National Institutes of Health; 6701 Rockledge Drive, Room 4166, MSC 7806; Bethesda, MD 20892; 301-435-2681; [email protected]. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: April 29, 2015. Carolyn Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015-10496 Filed 5-5-15; 8:45 am] BILLING CODE 4140-01-P
![26064 Federal Register / Vol. 80, No. 87 / Wednesday, May 6, 2015 / Notices
bioequivalence of clozapine products.2 Dated: April 30, 2015. Place: National Institutes of Health; 6701
FDA recommends that such studies be Leslie Kux, Rockledge Drive; Bethesda, MD 20892;
performed only in patients who have (Virtual Meeting).
Associate Commissioner for Policy.
Contact Person: Jane A. Doussard-
not responded well to standard [FR Doc. 2015–10478 Filed 5–5–15; 8:45 am] Roosevelt, Ph.D.; Scientific Review Officer;
antipsychotic drug treatment and who BILLING CODE 4164–01–P Center for Scientific Review; National
have been receiving a maintenance dose Institutes of Health; 6701 Rockledge Drive,
of an approved clozapine product for at Room 3184, MSC 7848; Bethesda, MD 20892;
least 3 months. FDA is now issuing a DEPARTMENT OF HEALTH AND (301) 435–4445; doussarj@csr.nih.gov.
draft guidance for industry on BE HUMAN SERVICES Name of Committee: Brain Disorders and
recommendations for generic clozapine Clinical Neuroscience Integrated Review
National Institutes of Health Group; Pathophysiological Basis of Mental
that applies specifically to the ODTs.
Disorders and Addictions Study Section.
Beckloff Associates, Inc., filed a Center for Scientific Review; Notice of Date: June 3–4, 2015.
citizen petition in December 2007, a Closed Meetings Time: 8:00 a.m. to 5:00 p.m.
citizen petition supplement in February Agenda: To review and evaluate grant
2009, and a second citizen petition in Pursuant to section 10(d) of the applications.
Federal Advisory Committee Act, as Place: The Warwick Allerton Hotel; 701
November 2010, requesting that FDA North Michigan Avenue; Chicago, IL 60611.
impose certain requirements for amended (5 U.S.C. App.), notice is
Contact Person: Boris P Sokolov, Ph.D.;
bioequivalence testing for ANDAs hereby given of the following meetings. Scientific Review Officer; Center for
referencing FazaClo (clozapine) ODTs The meetings will be closed to the Scientific Review; National Institutes of
and modify the Clozapine Guidance public in accordance with the Health; 6701 Rockledge Drive, Room 5217A,
(Docket Nos. FDA–2007–P–0188 and provisions set forth in sections MSC 7846; Bethesda, MD 20892; 301–408–
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 9115; bsokolov@csr.nih.gov.
FDA–2010–P–0574). FDA is denying
as amended. The grant applications and Name of Committee: Vascular and
these petitions today. Hematology Integrated Review Group;
the discussions could disclose
This draft guidance is being issued confidential trade secrets or commercial Molecular and Cellular Hematology Study
consistent with FDA’s good guidance Section.
property such as patentable material, Date: June 3–4, 2015.
practices regulation (21 CFR 10.115). and personal information concerning Time: 8:00 a.m. to 5:00 p.m.
The draft guidance, when finalized, will individuals associated with the grant Agenda: To review and evaluate grant
represent the current thinking of FDA applications, the disclosure of which applications.
on bioequivalence recommendations for would constitute a clearly unwarranted Place: Embassy Suites at the Chevy Chase
clozapine. It does not establish any invasion of personal privacy. Pavilion; 4300 Military Road NW.;
rights for any person and is not binding Washington, DC 20015.
Name of Committee: Center for Scientific Contact Person: Luis Espinoza, Ph.D.;
on FDA or the public. You can use an Review Special Emphasis Panel; PAR Panel:
alternative approach if it satisfies the Scientific Review Officer; Center for
Selected Topics and Transfusion Medicine. Scientific Review; National Institutes of
requirements of the applicable statutes Date: June 1–2, 2015. Health; 6701 Rockledge Drive, Room 6183,
and regulations. Time: 8:00 a.m. to 6:00 p.m. MSC 7804; Bethesda, MD 20892; 301–495–
Agenda: To review and evaluate grant 1213; espinozala@mail.nih.gov.
II. Comments applications. Name of Committee: Biobehavioral and
Place: National Institutes of Health; 6701 Behavioral Processes Integrated Review
Interested persons may submit either Rockledge Drive; Bethesda, MD 20892;
electronic comments regarding this Group; Cognition and Perception Study
(Virtual Meeting). Section.
document to http://www.regulations.gov Contact Person: Bukhtiar H Shah, DVM, Date: June 4–5, 2015.
or written comments to the Division of Ph.D.; Scientific Review Officer; Center for Time: 8:00 a.m. to 5:00 p.m.
Dockets Management (see ADDRESSES). It Scientific Review; National Institutes of Agenda: To review and evaluate grant
is only necessary to send one set of Health; 6701 Rockledge Drive, Room 4120, applications.
comments. Identify comments with the MSC 7802; Bethesda, MD 20892; 301–806– Place: Historic Inns of Annapolis; 58 State
7314; shahb@csr.nih.gov. Circle; Annapolis, MD 21401.
docket number found in brackets in the
heading of this document. Received Name of Committee: Center for Scientific Contact Person: Dana Jeffrey Plude, Ph.D.;
Review Special Emphasis Panel; PAR Panel: Scientific Review Officer; Center for
comments may be seen in the Division Selected Topics and Transfusion Medicine. Scientific Review; National Institutes of
of Dockets Management between 9 a.m. Date: June 1–2, 2015. Health; 6701 Rockledge Drive, Room 3176,
and 4 p.m., Monday through Friday, and Time: 8:00 a.m. to 6:00 p.m. MSC 7848; Bethesda, MD 20892; (301) 435–
will be posted to the docket at http:// Agenda: To review and evaluate grant 2309; pluded@csr.nih.gov.
www.regulations.gov. applications. Name of Committee: Biology of
Place: National Institutes of Health; 6701 Development and Aging Integrated Review
III. Electronic Access Rockledge Drive; Bethesda, MD 20892; Group; International and Cooperative
(Virtual Meeting). Projects—1 Study Section.
Persons with access to the Internet Contact Person: Katherine M Malinda, Date: June 4, 2015.
may obtain the documents at either Ph.D.; Scientific Review Officer; Center for Time: 8:00 a.m. to 6:00 p.m.
http://www.fda.gov/Drugs/ Scientific Review; National Institutes of Agenda: To review and evaluate grant
GuidanceCompliance Health; 6701 Rockledge Drive, Room 4140, applications.
RegulatoryInformation/Guidances/ MSC 7814; Bethesda, MD 20892; 301–435– Place: Villa Florence Hotel; 225 Powell
default.htm or http:// 0912; Katherine_Malinda@csr.nih.gov. Street; San Francisco, CA 94102.
Name of Committee: Center for Scientific Contact Person: Hilary D Sigmon, Ph.D.;
tkelley on DSK3SPTVN1PROD with NOTICES
www.regulations.gov.
Review Special Emphasis Panel; Child Scientific Review Officer; Center for
Psychopathology and Developmental Scientific Review; National Institutes of
2 The formatting of this guidance was updated in
Disabilities. Health; 6701 Rockledge Drive, Room 5222,
March 2011, but the content is unchanged. The MSC 7852; Bethesda, MD 20892; (301) 594–
March 2011 version is available at http:// Date: June 2–3, 2015.
www.fda.gov/downloads/Drugs/Guidance Time: 8:00 a.m. to 5:00 p.m. 6377; sigmonh@csr.nih.gov.
ComplianceRegulatoryInformation/Guidances/ Agenda: To review and evaluate grant Name of Committee: Risk, Prevention and
UCM249219.pdf. applications. Health Behavior Integrated Review Group;
VerDate Sep<11>2014 18:43 May 05, 2015 Jkt 235001 PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 E:\FR\FM\06MYN1.SGM 06MYN1](https://thefederalregister.org/doc/80_FR_26151/page/1.svg)
![Federal Register / Vol. 80, No. 87 / Wednesday, May 6, 2015 / Notices 26065
Psychosocial Development, Risk and Scientific Review; National Institute of Contact Person: ELENA SANOVICH, Ph.D.,
Prevention Study Section. Health; 6701 Rockledge Drive, Room 3213, SCIENTIFIC REVIEW OFFICER, REVIEW
Date: June 4–5, 2015. MSC 7808; Bethesda, MD 20892; 301–408– BRANCH, DEA, NIDDK, NATIONAL
Time: 8:00 a.m. to 6:00 p.m. 9519; burchjb@csr.nih.gov. INSTITUTES OF HEALTH, ROOM 750, 6707
Agenda: To review and evaluate grant Name of Committee: Biological Chemistry DEMOCRACY BOULEVARD, BETHESDA,
applications. and Macromolecular Biophysics Integrated MD 20892–2542, 301–594–8886, sanoviche@
Place: Kinzie Hotel; 20 W Kinzie Street; Review Group; Synthetic and Biological mail.nih.gov.
Chicago, IL 60654. Chemistry B Study Section.
Contact Person: Anna L Riley, Ph.D.; Name of Committee: National Institute of
Date: June 4–5, 2015. Diabetes and Digestive and Kidney Diseases
Scientific Review Officer; Center for Time: 8:30 a.m. to 5:00 p.m.
Scientific Review; National Institutes of Special Emphasis Panel; Fellowships in
Agenda: To review and evaluate grant
Health; 6701 Rockledge Drive, Room 3114, Digestive Diseases and Nutrition.
applications.
MSC 7759; Bethesda, MD 20892; (301) 435– Date: June 9–10, 2015.
Place: Pier 5 Hotel; 711 Eastern Avenue;
2889; rileyann@csr.nih.gov. Time: 8:00 a.m. to 6:00 p.m.
Baltimore, MD 21202.
Name of Committee: Emerging Contact Person: Kathryn M Koeller, Ph.D.; Agenda: To review and evaluate grant
Technologies and Training Neurosciences Scientific Review Officer; Center for applications.
Integrated Review Group; Molecular Scientific Review; National Institutes of Place: Melrose Hotel, 2430 Pennsylvania
Neurogenetics Study Section. Health; 6701 Rockledge Drive, Room 4166, Ave. NW., Washington, DC 20037.
Date: June 4–5, 2015. MSC 7806; Bethesda, MD 20892; 301–435– Contact Person: THOMAS A. TATHAM,
Time: 8:00 a.m. to 5:00 p.m. 2681; koellerk@csr.nih.gov. Ph.D., SCIENTIFIC REVIEW OFFICER,
Agenda: To review and evaluate grant (Catalogue of Federal Domestic Assistance REVIEW BRANCH, DEA, NIDDK,
applications. Program Nos. 93.306, Comparative Medicine; NATIONAL INSTITUTES OF HEALTH,
Place: Mayflower Park Hotel; 405 Olive 93.333, Clinical Research, 93.306, 93.333, ROOM 760, 6707 DEMOCRACY
Way; Seattle, WA 98101. 93.337, 93.393–93.396, 93.837–93.844, BOULEVARD, BETHESDA, MD 20892–5452,
Contact Person: Eugene Carstea, Ph.D.; 93.846–93.878, 93.892, 93.893, National (301) 594–3993, tathamt@mail.nih.gov.
Scientific Review Officer; Center for Institutes of Health, HHS) Name of Committee: National Institute of
Scientific Review; National Institutes of
Dated: April 29, 2015. Diabetes and Digestive and Kidney Diseases
Health; 6701 Rockledge Drive, Room 5194,
Special Emphasis Panel; DDK–C Conflicts.
MSC 7846; Bethesda, MD 20892; (301) 408– Carolyn Baum,
Date: June 10, 2015.
9756; carsteae@csr.nih.gov. Program Analyst, Office of Federal Advisory Time: 11:00 a.m. to 12:00 p.m.
Name of Committee: Immunology Committee Policy. Agenda: To review and evaluate grant
Integrated Review Group; Transplantation, [FR Doc. 2015–10496 Filed 5–5–15; 8:45 am] applications.
Tolerance, and Tumor Immunology Study Place: Melrose Hotel, 2430 Pennsylvania
BILLING CODE 4140–01–P
Section.
Ave. NW., Washington, DC 20037.
Date: June 4–5, 2015.
Contact Person: THOMAS A. TATHAM,
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant DEPARTMENT OF HEALTH AND Ph.D., SCIENTIFIC REVIEW OFFICER,
applications. HUMAN SERVICES REVIEW BRANCH, DEA, NIDDK,
Place: Marriott Wardman Park Washington NATIONAL INSTITUTES OF HEALTH,
DC Hotel; 2660 Woodley Road NW.; National Institutes of Health ROOM 760, 6707 DEMOCRACY
Washington, DC 20008. BOULEVARD, BETHESDA, MD 20892–5452,
Contact Person: Jin Huang, Ph.D.; National Institute of Diabetes and (301) 594–3993, tathamt@mail.nih.gov.
Scientific Review Officer; Center for Digestive and Kidney Diseases; Notice Name of Committee: National Institute of
Scientific Review; National Institutes of of Closed Meetings Diabetes and Digestive and Kidney Diseases
Health; 6701 Rockledge Drive, Room 4199, Special Emphasis Panel; U54 Urology
MSC 7812; Bethesda, MD 20892; 301–435– Pursuant to section 10(d) of the Research Center Applications.
1230; jh377p@nih.gov. Federal Advisory Committee Act, as Date: July 8–9, 2015.
Name of Committee: Immunology amended (5 U.S.C. App.), notice is Time: 5:00 p.m. to 5:00 p.m.
Integrated Review Group; Hypersensitivity, hereby given of the following meetings. Agenda: To review and evaluate grant
Autoimmune, and Immune-mediated applications.
The meetings will be closed to the
Diseases Study Section. Place: Hyatt Regency Bethesda, One
Date: June 4–5, 2015. public in accordance with the Bethesda Metro Center, 7400 Wisconsin
Time: 8:00 a.m. to 5:00 p.m. provisions set forth in sections Avenue, Bethesda, MD 20814.
Agenda: To review and evaluate grant 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Contact Person: JASON D. HOFFERT,
applications. as amended. The grant applications and Ph.D., SCIENTIFIC REVIEW OFFICER,
Place: Washington Plaza Hotel; 10 Thomas the discussions could disclose REVIEW BRANCH, DEA, NIDDK,
Circle, NW.; Washington, DC 20005. confidential trade secrets or commercial NATIONAL INSTITUTES OF HEALTH,
Contact Person: Bahiru Gametchu, DVM, property such as patentable material, ROOM 741A, 6707 DEMOCRACY
Ph.D.; Scientific Review Officer; Center for and personal information concerning BOULEVARD, BETHESDA, MD 20892542,
Scientific Review; National Institutes of 301–594–5404, hoffertj@niddk.nih.gov.
individuals associated with the grant
Health; 6701 Rockledge Drive, Room 4204,
MSC 7812; Bethesda, MD 20892; 301–408– applications, the disclosure of which (Catalogue of Federal Domestic Assistance
9329; gametchb@csr.nih.gov. would constitute a clearly unwarranted Program Nos. 93.847, Diabetes,
invasion of personal privacy. Endocrinology and Metabolic Research;
Name of Committee: Cell Biology
93.848, Digestive Diseases and Nutrition
Integrated Review Group; Cellular Name of Committee: National Institute of
Research; 93.849, Kidney Diseases, Urology
Mechanisms in Aging and Development Diabetes and Digestive and Kidney Diseases
and Hematology Research, National Institutes
Study Section. Special Emphasis Panel; Closed Loop
of Health, HHS)
Date: June 4–5, 2015. Technologies: Clinical Trails.
tkelley on DSK3SPTVN1PROD with NOTICES
Time: 8:30 a.m. to 6:00 p.m. Date: June 3, 2015. Dated: April 30, 2015.
Agenda: To review and evaluate grant Time: 8:00 a.m. to 12:00 p.m. David Clary,
applications. Agenda: To review and evaluate grant
Program Analyst, Office of Federal Advisory
Place: St. Gregory Hotel; 2033 M Street applications.
Committee Policy.
NW.; Washington, DC 20036. Place: National Institutes of Health, 6705
Contact Person: John Burch, Ph.D.; Rockledge Drive, Bethesda, MD 20817, [FR Doc. 2015–10540 Filed 5–5–15; 8:45 am]
Scientific Review Officer; Center for (Telephone Conference Call). BILLING CODE 4140–01–P
VerDate Sep<11>2014 18:43 May 05, 2015 Jkt 235001 PO 00000 Frm 00071 Fmt 4703 Sfmt 9990 E:\FR\FM\06MYN1.SGM 06MYN1](https://thefederalregister.org/doc/80_FR_26151/page/2.svg)
Document Created: 2015-12-16 07:40:46
Document Modified: 2015-12-16 07:40:46
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | June 1-2, 2015. | |
| FR Citation | 80 FR 26064 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR